SCIENJOY HOLDING CORP-A (SJ) Fundamental Analysis & Valuation

NASDAQ:SJ • VGG7864D1125

Current stock price

1.1 USD
-0.01 (-0.9%)
Last:

This SJ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. SJ Profitability Analysis

1.1 Basic Checks

  • In the past year SJ was profitable.
  • In the past year SJ had a positive cash flow from operations.
  • SJ had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years SJ had a positive operating cash flow.
SJ Yearly Net Income VS EBIT VS OCF VS FCFSJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • With a decent Return On Assets value of 0.79%, SJ is doing good in the industry, outperforming 68.35% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 0.92%, SJ is in the better half of the industry, outperforming 65.82% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 2.07%, SJ is doing good in the industry, outperforming 69.62% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SJ is significantly below the industry average of 159.06%.
Industry RankSector Rank
ROA 0.79%
ROE 0.92%
ROIC 2.07%
ROA(3y)4.52%
ROA(5y)10.17%
ROE(3y)5.76%
ROE(5y)15.32%
ROIC(3y)3.9%
ROIC(5y)9.89%
SJ Yearly ROA, ROE, ROICSJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • SJ's Profit Margin of 0.85% is fine compared to the rest of the industry. SJ outperforms 65.82% of its industry peers.
  • In the last couple of years the Profit Margin of SJ has declined.
  • Looking at the Operating Margin, with a value of 2.92%, SJ is in the better half of the industry, outperforming 68.35% of the companies in the same industry.
  • SJ's Operating Margin has declined in the last couple of years.
  • SJ's Gross Margin of 18.88% is on the low side compared to the rest of the industry. SJ is outperformed by 78.48% of its industry peers.
  • SJ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.92%
PM (TTM) 0.85%
GM 18.88%
OM growth 3Y-33.03%
OM growth 5Y-29.41%
PM growth 3Y-34.13%
PM growth 5Y-29.22%
GM growth 3Y-0.44%
GM growth 5Y-3.23%
SJ Yearly Profit, Operating, Gross MarginsSJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

8

2. SJ Health Analysis

2.1 Basic Checks

  • SJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • SJ has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SJ has more shares outstanding
  • SJ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SJ Yearly Shares OutstandingSJ Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SJ Yearly Total Debt VS Total AssetsSJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • SJ has an Altman-Z score of 2.96. This is not the best score and indicates that SJ is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.96, SJ is in the better half of the industry, outperforming 78.48% of the companies in the same industry.
  • SJ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.96
ROIC/WACC0.28
WACC7.54%
SJ Yearly LT Debt VS Equity VS FCFSJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • SJ has a Current Ratio of 3.48. This indicates that SJ is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of SJ (3.48) is better than 91.14% of its industry peers.
  • A Quick Ratio of 3.48 indicates that SJ has no problem at all paying its short term obligations.
  • SJ has a Quick ratio of 3.48. This is amongst the best in the industry. SJ outperforms 91.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.48
Quick Ratio 3.48
SJ Yearly Current Assets VS Current LiabilitesSJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. SJ Growth Analysis

3.1 Past

  • SJ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.55%.
  • Measured over the past years, SJ shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.33% on average per year.
  • The Revenue has decreased by -9.07% in the past year.
  • Measured over the past years, SJ shows a quite strong growth in Revenue. The Revenue has been growing by 8.31% on average per year.
EPS 1Y (TTM)-63.55%
EPS 3Y-44.25%
EPS 5Y-28.33%
EPS Q2Q%765.59%
Revenue 1Y (TTM)-9.07%
Revenue growth 3Y-6.53%
Revenue growth 5Y8.31%
Sales Q2Q%-5.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SJ Yearly Revenue VS EstimatesSJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

4. SJ Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.33, SJ is valued on the expensive side.
  • Based on the Price/Earnings ratio, SJ is valued cheaply inside the industry as 88.61% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of SJ to the average of the S&P500 Index (27.42), we can say SJ is valued slightly cheaper.
Industry RankSector Rank
PE 18.33
Fwd PE N/A
SJ Price Earnings VS Forward Price EarningsSJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SJ indicates a rather cheap valuation: SJ is cheaper than 97.47% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SJ indicates a rather cheap valuation: SJ is cheaper than 98.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.69
EV/EBITDA 0.15
SJ Per share dataSJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. SJ Dividend Analysis

5.1 Amount

  • SJ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SJ Fundamentals: All Metrics, Ratios and Statistics

SCIENJOY HOLDING CORP-A

NASDAQ:SJ (4/24/2026, 8:08:30 PM)

1.1

-0.01 (-0.9%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)04-24
Earnings (Next)06-02
Inst Owners0.23%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap46.57M
Revenue(TTM)1.31B
Net Income(TTM)11.26M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.33
Fwd PE N/A
P/S 0.24
P/FCF 2.69
P/OCF 2.67
P/B 0.26
P/tB 0.5
EV/EBITDA 0.15
EPS(TTM)0.06
EY5.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY37.17%
OCF(TTM)0.41
OCFY37.48%
SpS4.59
BVpS4.21
TBVpS2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.38472 (116.79%)
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 0.92%
ROCE 3.05%
ROIC 2.07%
ROICexc 2.73%
ROICexgc 6.91%
OM 2.92%
PM (TTM) 0.85%
GM 18.88%
FCFM 8.91%
ROA(3y)4.52%
ROA(5y)10.17%
ROE(3y)5.76%
ROE(5y)15.32%
ROIC(3y)3.9%
ROIC(5y)9.89%
ROICexc(3y)4.8%
ROICexc(5y)15.26%
ROICexgc(3y)11.69%
ROICexgc(5y)N/A
ROCE(3y)5.76%
ROCE(5y)14.57%
ROICexgc growth 3Y-44.13%
ROICexgc growth 5Y-50.35%
ROICexc growth 3Y-46.72%
ROICexc growth 5Y-58.97%
OM growth 3Y-33.03%
OM growth 5Y-29.41%
PM growth 3Y-34.13%
PM growth 5Y-29.22%
GM growth 3Y-0.44%
GM growth 5Y-3.23%
F-Score7
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 11.99%
Cap/Sales 0.07%
Interest Coverage 250
Cash Conversion 253.45%
Profit Quality 1051.23%
Current Ratio 3.48
Quick Ratio 3.48
Altman-Z 2.96
F-Score7
WACC7.54%
ROIC/WACC0.28
Cap/Depr(3y)15.13%
Cap/Depr(5y)24.47%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.55%
EPS 3Y-44.25%
EPS 5Y-28.33%
EPS Q2Q%765.59%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.07%
Revenue growth 3Y-6.53%
Revenue growth 5Y8.31%
Sales Q2Q%-5.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.16%
EBIT growth 3Y-37.4%
EBIT growth 5Y-23.55%
EBIT Next Year714.3%
EBIT Next 3Y173.29%
EBIT Next 5Y128.25%
FCF growth 1Y-33.73%
FCF growth 3Y-16.15%
FCF growth 5Y-21.58%
OCF growth 1Y-33.09%
OCF growth 3Y-16.09%
OCF growth 5Y-21.39%

SCIENJOY HOLDING CORP-A / SJ Fundamental Analysis FAQ

What is the fundamental rating for SJ stock?

ChartMill assigns a fundamental rating of 4 / 10 to SJ.


Can you provide the valuation status for SCIENJOY HOLDING CORP-A?

ChartMill assigns a valuation rating of 4 / 10 to SCIENJOY HOLDING CORP-A (SJ). This can be considered as Fairly Valued.


Can you provide the profitability details for SCIENJOY HOLDING CORP-A?

SCIENJOY HOLDING CORP-A (SJ) has a profitability rating of 4 / 10.


Can you provide the financial health for SJ stock?

The financial health rating of SCIENJOY HOLDING CORP-A (SJ) is 8 / 10.